Cantor Fitzgerald reaffirmed its Overweight rating on Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) with a consistent price target of $480.00. According to InvestingPro data, Vertex, a prominent ...
This charming hilltop village is one of the most beautiful in France. Wander its cobbled streets and explore historic sites ...
Click the FOLLOW button to be the first to know about this artist's upcoming lots, sold lots, exhibitions and articles ...
Reshma Kewalramani; President, Chief Executive Officer, Director; Vertex Pharmaceuticals Inc Stuart Arbuckle; Chief Operating Officer, Executive Vice President; Vertex Pharmaceuticals Inc Charles ...